ABOUT 8th_IOIF
> ATTENDEES
> INVESTORS
> SHOWCASES
> SPONSORS
> SUPPORTERS

3B Future Health Ventures
AbbVie Ventures
AbbVie, Inc.
Actym Therapeutics, Inc.
AdBio Partners
Adimab, LLC
Aisling Capital LLC
Aleta Biotherapeutics
Allele Capital Partners, LLC
ALSA Ventures
Alta Life Sciences
Angel Investor
Aqua Partners LLC
ARCH Venture Partners
ARDAN PHARMA USA, INC.
Asklepios Advisors
Astellas Pharma, Inc.
Astia, Inc.
ATEM Capital LLC
Atlas Capital Markets
AUM Biosciences Pte. Ltd.
AVANTECA Partners AG
Avestria Ventures
Avstera Therapeutics Corp.
Bayer AG
Bayer U.S. LLC
BeiGene Ltd.
Bio Med Gene Ventures
BioMedPartners AG
BioNTech SE
Bioqube Ventures
BIOSTART Consulting GmbH
Bpifrance
Bradley Woods & Co. Ltd.
Brandon Capital Partners
Breslin AG
Bristol Myers Squibb
BROTHERS & Partners Europe
Bryan, Garnier & Co
BTIG, LLC
BVF Partners, L.P.
Cancer Research Institute
Capital Family Office
Carisma Therapeutics, Inc.
Catalytic Impact Foundation, Inc.
CBT Advisors
Claris Ventures
Codagenix Inc.
Cowen, Inc.
CSPC Pharmaceutical Group Limited
Cytimmune Sciences
Cytovation ASA
Dana-Farber Cancer Institute
Deca Ventures, LLC
Easton Capital Investment Group
Elicio Therapeutics, Inc.
EQRx
European Investment Bank
EVOLUTION Life Sciences Partners
FACIT
Ferghana Partners LLP
Fonds de Solidarité FTQ
Foothill Ventures
Forbion
Forty51 Ventures
Fraser Finance LLP
FreeMind Group
GCF Family Office
Generation Fund Life Sciences Fund I
Global Health Investment Corporation
Globescape Capital Inc.
GLSV GmbH iL, MicroCures Inc, Neurevo GmbH
GreenSky Capital, Inc.
Gritstone bio, Inc.
Harvard Medical School
HBM Partners AG
Health Innovation Capital
HealthCap
Hercules Technology Growth Capital, Inc
HiDEL Bio
High-Tech Gründerfonds (HTGF)
Howard FINGERT Consulting
IAG, Image Analysis Group
IBB Ventures
ICF Consult Switzerland
Illumina Ventures
Illumina, Inc.
Immuneering Corporation
Immunicom, Inc.

Indaco Venture Partners SGR SpA
Inhibrx
Invivo Capital Partners, S.G.E.I.C, S.A.
IPF Partners
Ipsen
Jeito Capital
Johnson & Johnson Innovation LLC
Kreos Capital
Landmark Angels, Inc.
Lazard Ltd.
LianBio
Lightstone Ventures
Lokon Pharma AB
Loncar Investments, LLC
Lumanity
Lumira Ventures
LYFE Capital
M Ventures
Mass General Brigham Ventures
Medicxi
Mediqventures
Mehta Partners LLC
Merck & Co., Inc.
Merck KGaA, Darmstadt, Germany
MetaCell LLC
Metaclipse Therapeutics
Nanobiotix Corp.
Nextech Invest Ltd.
Nexter Ventures., Co., Ltd.
NRW.BANK
NuvOx Pharma
NxR Biotechnologies GmbH
O'Melveny & Myers LLP
Odimma Therapeutics
Optimum Strategic Communications
OrbiMed Advisors LLC
OSE Immunotherapeutics
Panakès Partners SGR SpA
PharmaVentures Ltd
PharmaVentures Ltd.
Photon Fund
Pio Therapeutics Pty Ltd
Pivotal bioVenture Partners
Point32Health, Inc.
Prescient Therapeutics Ltd.
Prevail Partners LLC
Privateq Advisors AG
Prokarium Ltd.
Pureos Bioventures
Raymond James
Real Endpoints LLC
Remiges Ventures
Sandhill Angels
Silicon Valley Bank
SIWA Therapeutics, Inc.
Sound Bioventures Management AB
Stanphyl Capital
SternAegis Ventures
Strand Therapeutics
Syndivia
Taiho Ventures, LLC
TargImmune Therapeutics AG
Targovax ASA
The Catalytic Impact Foundation, Inc.
The Janssen Pharmaceutical Companies of Johnson & Johnson
The Leukemia & Lymphoma Society
The Mark Foundation for Cancer Research
The New York Academy of Sciences
Thomas Conseil
Thuja Capital Management B.V
Torreya
Toscana Ventures, LLC
Tracon Pharmaceuticals, Inc
TransPacific Venture Capital Partners
Triumvira Immunologics, Inc.
TVM Capital Life Science Venture Capital
UbiVac, Inc.
Valo Therapeutics Oy
Valor Management S.A.
Venrock
Vogel BioC
VU Venture Partners
WBB Securities, LLC
Wille Finance AG
XOventure GmbH
Yorkville Advisors Global, LP
Yunion Healthcare Ventures
Zumutor Biologics, Inc.
More TBA...

Last updated: 24th of May